<DOC>
	<DOCNO>NCT01783834</DOCNO>
	<brief_summary>To compare efficacy gefitinib versus pemetrexed second-line chemotherapy patient previous treat non-small cell lung cancer</brief_summary>
	<brief_title>Gefitinib Versus Pemetrexed Previously Treated NSCLC Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Cells pathologically diagnose histological radical surgery radiation therapy possible stage IIIB stage IV nonsmallcell lung cancer patient second line ECOG 0ï½ž2 Patients normal liver function renal function Patients severe acute infection require antibiotic therapy Patients receive treatment area cancer within 5 year During pregnancy lactation patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Pemetrexed</keyword>
	<keyword>Gefitinib</keyword>
	<keyword>iressa</keyword>
	<keyword>alimta</keyword>
</DOC>